Infections Deaths in the PLATO Trial

Background Cardiovascular benefits of aggressive dual antiplatelet therapy may be associated with extra risks including bleeding, cancer, and infections discovered first for prasugrel in the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel (TRITON)...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Victor Serebruany, Jean-Francois Tanguay
Format: article
Langue:EN
Publié: Georg Thieme Verlag KG 2021
Sujets:
Accès en ligne:https://doaj.org/article/21f0efbfbda84e639dc973214dd37e3d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!